| Application no. and date | 11728594.0 (espacenet) (Federated) (European Patent Register), 20110527 | | Patent/reg. no. and date | DK/EP 2575881, 20160914 | | Publication date | 20130410 | | Priority no. and date | US 349271 P, 20100528 | | EP pub. no. and date |
EP 2575881 20130410 | | Effective date | | | Applicant/owner | INSERM - Institut National de la Santé et de la
Recherche Médicale, 101, rue de Tolbiac
75013 Paris, FR,
Elsalys Biotech, 321 avenue Jean Jaures
69007 Lyon, FR | | Applicant ref. no. | P22448DKEP | | Inventor | LE BOUTEILLER, Philippe, INSERM , Unité U563
Hôpital Purpan
BP 3028 - Bâtiment A
F-31024 Toulouse Cédex 3, FR,
BENSUSSAN, Armand, INSERM U976 - Hôpital Saint Louis
Centre de Recherche sur la Peau
1 Av Claude Vellefaux
F-75010 Paris, FR | | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) , A61K 9/00 (2006.01) , A61P 27/02 (2006.01) , C07K 16/22 (2006.01) , C07K 16/28 (2006.01) | | Title | Specifikke anti-CD160-antilegemer for behandling af øjensygdomme på grundlag af neoangiogenese | | Int. application no. | EP2011058777 | | Int. publication no. | WO2011147984 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
